MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The impact of anxiety symptoms and treatment on Parkinson’s disease-related disability: findings from the Parkinson’s Progression Markers Initiative

    N. Dahodwala, D. Weintraub, M. Bock, R. Cho, C. Caspell-Garcia, E. Brown, R. Dobkin (Philadelphia, USA)

    Objective: To determine the functional consequences of baseline anxiety symptoms and the longer-term impact of initiation of anxiety treatment in Parkinson’s disease (PD). Background: While…
  • 2023 International Congress

    Hemifacial Spasm: Recent experience in a movement disorders reference center in Chile

    P. Salles, X. Pizarro, P. Chana, E. Betancur, I. Sanchez (Santiago, Chile)

    Objective: To analyze the demographic characteristics of patients with HFS and their response to different BoNT at the center for movement disorders CETRAM in Santiago,…
  • 2023 International Congress

    Safinamide in Parkinson´s Disease. A retrospective study

    M. Carmona-Abellan, M. Erburu, A. Cabrera, C. Garcia-Monco, K. Berganzo, B. Huete (Bilbao, Spain)

    Objective: To evaluate the safety of safinamide in Parkinson´s Disease (PD) and determine consequences of direct switch from rasagiline. Background: A wash-out period is recommended…
  • 2023 International Congress

    Deep Brain Stimulation for Orthostatic Tremor: An observational study’

    W. Babeliowsky, M. Bot, W. Potters, P. Vanden Munckhof, E. Blok, R. de Bie, P. Schuurman, AF. van Rootselaar (Amsterdam, Netherlands)

    Objective: To evaluate the efficacy of stimulation near the DRT on OT, based on standing time and QoL, and relate the proximity of stimulation to…
  • 2023 International Congress

    A Phase 2, Double-blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults with Isolated Cervical Dystonia

    J. Jankovic, C. Oh, Y. Liu, C. Comella (Irvine, USA)

    Objective: To evaluate the safety and the efficacy of ABP-450 (prabotulinumtoxinA) in patients with cervical dystonia (CD). Background: ABP-450 (prabotulinumtoxinA) is a new 900kDA botulinumtoxinA.…
  • 2023 International Congress

    Pilot study incorporating outcome measures after paediatric deep brain stimulation with patient and carer expectations and satisfaction

    J. Barnacoat, S. Mohammad, K. Stewart, J. Lewis, S. Coombes, M-C. Waugh, M. Farrar, K. Alba-Concepcion, B. Owler, N. Mahant, R. Dale, S. Paget (Westmead, Australia)

    Objective: To pilot a multi-faceted evaluation framework for paediatric patients undergoing deep brain stimulation (DBS) in a single centre. Background: DBS can be useful for…
  • 2023 International Congress

    Sleep disorders in Parkinson’s disease patients. A case-control study.

    L. Rotaru, M. Cebuc, A. Lupușor, O. Grosu, S. Odobescu, O. Gavriliuc, I. Moldovanu (Chisinau, Republic of Moldova)

    Objective: To determine the quality of sleep, the type of sleep disorders and their correlations with motor impairment in Parkinson's disease (PD) patients. Background: Sleep…
  • 2023 International Congress

    The effect of exercise training on motor and non-motor symptoms in people with Essential Tremor; a feasibility pilot study

    H. Khalil, M. Nazzal, A. Al-Sharman, L. Samman, D. Al-Shorafat, K. El-Salem, H. Al Refa’I, S. Obeidat (Doha, Qatar)

    Objective: To examine the potential benefits of an exercise program on motor and non-motor symptoms in people with Essential Tremor (ET) Background: Besides tremor, patients…
  • 2023 International Congress

    Caregiver burden in Parkinson disease: an updated scoping review

    J. Corcoran, W. Aamodt, S. Seshadri, M. Mirham, A. Job, S. Lettenberger, B. Kluger (Rochester, USA)

    Objective: We performed a scoping review to describe caregiver burden in Parkinson disease (PD) and build on the evidence provided by Mosely at al. [1]…
  • 2023 International Congress

    Very high frequency of early-onset Parkinson’s disease with homozygous PRKN exon 3 deletion amongst indigenous populations in Sabah, Malaysia

    YW. Tay, JCE. Ooi, SY. Lim, YK. Chia, A. Sukri, TS. Toh, JL. Lim, AH. Tan, A. Ahmad-Annuar (Kuala Lumpur, Malaysia)

    Objective: We aimed to investigate the frequency of EOPD and PRKN mutations in our diverse Malaysian indigenous populations, who are extremely under-represented in PD genetics…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley